Founded in Quebec City in 2015, diaMentis is the first company to develop a software as medical device (SaMD) that analyses information from a simple examination of the eye (electroretinography).

Mission: Develop, valorise, patent and market (directly or indirectly) a diagnostic tool for better management of patients with mental disorders in a personalised healthcare environment.

diaMentis value proposition:
• A non-invasive, not expensive and easy to implement test
• A reliable method of analysis
• Fast results via a centralized service

diaMentis technology will lead to:
• More accurate and faster diagnosis
• Appropriate choice of treatments and psychotherapy
• Better acceptance of the disease by the patient and better monitoring of treatments
• Reduction in relapses
• Decrease in duration and number of hospitalizations
• Return to work faster (reduction of disability premiums and family pressure)

diaMentis

Org chart

Teams

Offices